| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.24e-04 | 67 | 29 | 3 | GO:0031492 | |
| GeneOntologyMolecularFunction | nucleosome binding | 3.82e-04 | 98 | 29 | 3 | GO:0031491 | |
| Domain | Cadherin_tail | 2.99e-07 | 37 | 29 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 2.99e-07 | 37 | 29 | 4 | IPR031904 | |
| Domain | Cadherin_C_2 | 5.04e-07 | 42 | 29 | 4 | PF16492 | |
| Domain | Cadherin_C | 5.04e-07 | 42 | 29 | 4 | IPR032455 | |
| Domain | Cadherin_N | 2.97e-06 | 65 | 29 | 4 | IPR013164 | |
| Domain | Cadherin_2 | 2.97e-06 | 65 | 29 | 4 | PF08266 | |
| Domain | HMG14_17 | 2.32e-05 | 5 | 29 | 2 | PS00355 | |
| Domain | HMG14_17 | 2.32e-05 | 5 | 29 | 2 | PF01101 | |
| Domain | HMG17 | 2.32e-05 | 5 | 29 | 2 | SM00527 | |
| Domain | HMGN_fam | 2.32e-05 | 5 | 29 | 2 | IPR000079 | |
| Domain | Cadherin_CS | 2.33e-05 | 109 | 29 | 4 | IPR020894 | |
| Domain | Cadherin | 2.68e-05 | 113 | 29 | 4 | PF00028 | |
| Domain | CADHERIN_1 | 2.68e-05 | 113 | 29 | 4 | PS00232 | |
| Domain | CADHERIN_2 | 2.78e-05 | 114 | 29 | 4 | PS50268 | |
| Domain | - | 2.78e-05 | 114 | 29 | 4 | 2.60.40.60 | |
| Domain | CA | 2.88e-05 | 115 | 29 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.98e-05 | 116 | 29 | 4 | IPR015919 | |
| Domain | Cadherin | 3.18e-05 | 118 | 29 | 4 | IPR002126 | |
| Domain | AAA+_ATPase | 2.09e-02 | 144 | 29 | 2 | IPR003593 | |
| Domain | AAA | 2.09e-02 | 144 | 29 | 2 | SM00382 | |
| Pubmed | RALY HMGN2 NCL CHD6 RRBP1 SPAG17 ZNF608 PCDHGB2 HMGN4 ATP2B1 PCDHGA10 PCDHGA5 PCDHGA1 PRRC2B H1-2 | 7.68e-14 | 1442 | 29 | 15 | 35575683 | |
| Pubmed | 4.59e-08 | 655 | 29 | 8 | 35819319 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 5.15e-08 | 1294 | 29 | 10 | 30804502 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.26e-07 | 807 | 29 | 8 | 22681889 | |
| Pubmed | 2.36e-07 | 15 | 29 | 3 | 28190768 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 3.06e-07 | 68 | 29 | 4 | 11230163 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 3.86e-07 | 72 | 29 | 4 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 4.31e-07 | 74 | 29 | 4 | 10817752 | |
| Pubmed | 5.06e-07 | 77 | 29 | 4 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 5.90e-07 | 80 | 29 | 4 | 10716726 | |
| Pubmed | HMGN4, a newly discovered nucleosome-binding protein encoded by an intronless gene. | 6.71e-07 | 2 | 29 | 2 | 11410162 | |
| Pubmed | 8.59e-07 | 652 | 29 | 7 | 31180492 | ||
| Pubmed | 9.28e-07 | 216 | 29 | 5 | 37640791 | ||
| Pubmed | 1.26e-06 | 1014 | 29 | 8 | 32416067 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.39e-06 | 701 | 29 | 7 | 30196744 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 37371543 | ||
| Pubmed | 3.00e-06 | 1139 | 29 | 8 | 36417873 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 4.85e-06 | 847 | 29 | 7 | 35235311 | |
| Pubmed | 5.85e-06 | 1247 | 29 | 8 | 27684187 | ||
| Pubmed | 6.05e-06 | 317 | 29 | 5 | 30997501 | ||
| Pubmed | Isolation, mapping, and regulated expression of the gene encoding mouse C-type natriuretic peptide. | 6.70e-06 | 5 | 29 | 2 | 8897953 | |
| Pubmed | 7.22e-06 | 45 | 29 | 3 | 33596420 | ||
| Pubmed | 7.79e-06 | 334 | 29 | 5 | 30425250 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 9.17e-06 | 934 | 29 | 7 | 33916271 | |
| Pubmed | RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription. | 9.95e-06 | 50 | 29 | 3 | 30413534 | |
| Pubmed | 1.00e-05 | 615 | 29 | 6 | 31048545 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.02e-05 | 949 | 29 | 7 | 36574265 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.05e-05 | 954 | 29 | 7 | 36373674 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 1.11e-05 | 626 | 29 | 6 | 33644029 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.13e-05 | 361 | 29 | 5 | 26167880 | |
| Pubmed | 2.31e-05 | 713 | 29 | 6 | 29802200 | ||
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 2.39e-05 | 203 | 29 | 4 | 24244333 | |
| Pubmed | 2.48e-05 | 205 | 29 | 4 | 27976729 | ||
| Pubmed | 2.89e-05 | 1116 | 29 | 7 | 31753913 | ||
| Pubmed | 3.45e-05 | 223 | 29 | 4 | 33731348 | ||
| Pubmed | 3.45e-05 | 223 | 29 | 4 | 20020773 | ||
| Pubmed | 3.57e-05 | 225 | 29 | 4 | 12168954 | ||
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 32853985 | ||
| Pubmed | 4.30e-05 | 236 | 29 | 4 | 36339263 | ||
| Pubmed | 4.49e-05 | 803 | 29 | 6 | 36517590 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 4.61e-05 | 807 | 29 | 6 | 30575818 | |
| Pubmed | Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. | 4.75e-05 | 84 | 29 | 3 | 19135240 | |
| Pubmed | 4.93e-05 | 491 | 29 | 5 | 36273042 | ||
| Pubmed | 5.21e-05 | 13 | 29 | 2 | 19836239 | ||
| Pubmed | 5.45e-05 | 88 | 29 | 3 | 26318153 | ||
| Pubmed | 5.53e-05 | 503 | 29 | 5 | 16964243 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 6.15e-05 | 1257 | 29 | 7 | 37317656 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 6.45e-05 | 262 | 29 | 4 | 36880596 | |
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 23515096 | ||
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 28784777 | ||
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 7.07e-05 | 96 | 29 | 3 | 25948554 | |
| Pubmed | 7.49e-05 | 1297 | 29 | 7 | 33545068 | ||
| Pubmed | 7.99e-05 | 277 | 29 | 4 | 30745168 | ||
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 18258596 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 8.28e-05 | 1318 | 29 | 7 | 30463901 | |
| Pubmed | 8.50e-05 | 551 | 29 | 5 | 34728620 | ||
| Pubmed | 8.57e-05 | 282 | 29 | 4 | 23667531 | ||
| Pubmed | 9.04e-05 | 286 | 29 | 4 | 32041737 | ||
| Pubmed | Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage. | 9.06e-05 | 17 | 29 | 2 | 21825151 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 9.17e-05 | 287 | 29 | 4 | 36180891 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 9.76e-05 | 1353 | 29 | 7 | 29467282 | |
| Pubmed | 1.02e-04 | 295 | 29 | 4 | 26209609 | ||
| Pubmed | 1.28e-04 | 971 | 29 | 6 | 33306668 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.35e-04 | 1425 | 29 | 7 | 30948266 | |
| Pubmed | 1.38e-04 | 1431 | 29 | 7 | 37142655 | ||
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 1.40e-04 | 21 | 29 | 2 | 33029523 | |
| Pubmed | 1.40e-04 | 121 | 29 | 3 | 34029587 | ||
| Pubmed | 1.47e-04 | 123 | 29 | 3 | 35583604 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 1.55e-04 | 329 | 29 | 4 | 34316702 | |
| Pubmed | 1.57e-04 | 330 | 29 | 4 | 21044950 | ||
| Pubmed | 1.69e-04 | 638 | 29 | 5 | 31182584 | ||
| Pubmed | 1.83e-04 | 24 | 29 | 2 | 24698270 | ||
| Pubmed | 1.83e-04 | 24 | 29 | 2 | 33722704 | ||
| Pubmed | 1.98e-04 | 136 | 29 | 3 | 25429064 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.98e-04 | 351 | 29 | 4 | 38297188 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 2.03e-04 | 353 | 29 | 4 | 27545878 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.04e-04 | 665 | 29 | 5 | 30457570 | |
| Pubmed | 2.33e-04 | 27 | 29 | 2 | 19602484 | ||
| Pubmed | The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1. | 2.50e-04 | 28 | 29 | 2 | 22234250 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 2.50e-04 | 28 | 29 | 2 | 15347688 | |
| Pubmed | 2.50e-04 | 28 | 29 | 2 | 26381412 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 2.55e-04 | 375 | 29 | 4 | 32788342 | |
| Pubmed | 2.70e-04 | 151 | 29 | 3 | 18457437 | ||
| Pubmed | 2.78e-04 | 711 | 29 | 5 | 33022573 | ||
| Pubmed | 2.80e-04 | 153 | 29 | 3 | 28225217 | ||
| Pubmed | Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP. | 2.88e-04 | 30 | 29 | 2 | 22963397 | |
| Pubmed | RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway. | 2.97e-04 | 156 | 29 | 3 | 26170170 | |
| Pubmed | 3.08e-04 | 31 | 29 | 2 | 26678539 | ||
| Pubmed | 3.16e-04 | 731 | 29 | 5 | 29298432 | ||
| Pubmed | 3.23e-04 | 399 | 29 | 4 | 35987950 | ||
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 3.28e-04 | 32 | 29 | 2 | 15848144 | |
| Pubmed | 3.28e-04 | 32 | 29 | 2 | 27158335 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 3.38e-04 | 163 | 29 | 3 | 22113938 | |
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 3.70e-04 | 34 | 29 | 2 | 22884324 | |
| Pubmed | The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma. | 3.70e-04 | 34 | 29 | 2 | 36059274 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.76e-04 | 759 | 29 | 5 | 35915203 | |
| Pubmed | 3.82e-04 | 417 | 29 | 4 | 36537216 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 3.92e-04 | 420 | 29 | 4 | 28065597 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 4.06e-04 | 1203 | 29 | 6 | 29180619 | |
| Pubmed | 4.10e-04 | 425 | 29 | 4 | 24999758 | ||
| Interaction | H2BC5 interactions | HMGN2 NCL SERBP1 PCDHGB2 HMGN4 PCDHGA10 PCDHGA5 PCDHGA1 H1-2 | 5.85e-10 | 331 | 29 | 9 | int:H2BC5 |
| Interaction | H2BC12 interactions | 2.87e-07 | 322 | 29 | 7 | int:H2BC12 | |
| Interaction | H2BC4 interactions | 1.58e-06 | 259 | 29 | 6 | int:H2BC4 | |
| Interaction | H2BC9 interactions | 2.54e-06 | 446 | 29 | 7 | int:H2BC9 | |
| Interaction | RNF113A interactions | 4.20e-06 | 692 | 29 | 8 | int:RNF113A | |
| Interaction | H2BC18 interactions | 5.37e-06 | 180 | 29 | 5 | int:H2BC18 | |
| Interaction | ALG13 interactions | 5.82e-06 | 183 | 29 | 5 | int:ALG13 | |
| Interaction | CYB5R1 interactions | 3.16e-05 | 127 | 29 | 4 | int:CYB5R1 | |
| Interaction | PCDHGB2 interactions | 3.41e-05 | 44 | 29 | 3 | int:PCDHGB2 | |
| Interaction | H1-2 interactions | 3.45e-05 | 666 | 29 | 7 | int:H1-2 | |
| Interaction | CBX6 interactions | 4.75e-05 | 283 | 29 | 5 | int:CBX6 | |
| Interaction | PCDHB3 interactions | 4.76e-05 | 141 | 29 | 4 | int:PCDHB3 | |
| Interaction | RAB5A interactions | 5.00e-05 | 706 | 29 | 7 | int:RAB5A | |
| Interaction | H2AC14 interactions | 5.17e-05 | 144 | 29 | 4 | int:H2AC14 | |
| Interaction | USP14 interactions | 5.85e-05 | 489 | 29 | 6 | int:USP14 | |
| Interaction | NUP42 interactions | 5.90e-05 | 149 | 29 | 4 | int:NUP42 | |
| Interaction | SYNGAP1 interactions | 6.98e-05 | 307 | 29 | 5 | int:SYNGAP1 | |
| Interaction | RLIG1 interactions | 7.15e-05 | 9 | 29 | 2 | int:RLIG1 | |
| Interaction | EPRS1 interactions | 7.62e-05 | 513 | 29 | 6 | int:EPRS1 | |
| Interaction | KIF20A interactions | 8.62e-05 | 1052 | 29 | 8 | int:KIF20A | |
| Interaction | TERF2 interactions | 1.13e-04 | 340 | 29 | 5 | int:TERF2 | |
| Interaction | SOX2 interactions | 1.16e-04 | 1422 | 29 | 9 | int:SOX2 | |
| Interaction | FOXO1 interactions | 1.24e-04 | 347 | 29 | 5 | int:FOXO1 | |
| Interaction | SREK1 interactions | 1.31e-04 | 183 | 29 | 4 | int:SREK1 | |
| Interaction | CIT interactions | 1.35e-04 | 1450 | 29 | 9 | int:CIT | |
| Interaction | H2BC11 interactions | 1.39e-04 | 186 | 29 | 4 | int:H2BC11 | |
| Interaction | ATN1 interactions | 1.42e-04 | 187 | 29 | 4 | int:ATN1 | |
| Interaction | CDK1 interactions | 1.64e-04 | 590 | 29 | 6 | int:CDK1 | |
| Interaction | H2AC13 interactions | 1.69e-04 | 75 | 29 | 3 | int:H2AC13 | |
| Interaction | PRG4 interactions | 1.80e-04 | 14 | 29 | 2 | int:PRG4 | |
| Interaction | DCAF4 interactions | 1.85e-04 | 378 | 29 | 5 | int:DCAF4 | |
| Interaction | H3C15 interactions | 2.10e-04 | 207 | 29 | 4 | int:H3C15 | |
| Interaction | ABCF2 interactions | 2.18e-04 | 209 | 29 | 4 | int:ABCF2 | |
| Interaction | H2BC13 interactions | 2.22e-04 | 210 | 29 | 4 | int:H2BC13 | |
| Interaction | RNF31 interactions | 2.49e-04 | 403 | 29 | 5 | int:RNF31 | |
| Interaction | H2BC3 interactions | 2.58e-04 | 406 | 29 | 5 | int:H2BC3 | |
| Interaction | CTBP1 interactions | 2.58e-04 | 406 | 29 | 5 | int:CTBP1 | |
| Interaction | UNK interactions | 2.64e-04 | 408 | 29 | 5 | int:UNK | |
| Interaction | SLCO6A1 interactions | 2.68e-04 | 17 | 29 | 2 | int:SLCO6A1 | |
| Interaction | HMGN2 interactions | 2.74e-04 | 222 | 29 | 4 | int:HMGN2 | |
| Interaction | BMI1 interactions | 2.98e-04 | 659 | 29 | 6 | int:BMI1 | |
| Interaction | BRF1 interactions | 3.09e-04 | 92 | 29 | 3 | int:BRF1 | |
| Interaction | RPS15 interactions | 3.12e-04 | 423 | 29 | 5 | int:RPS15 | |
| Interaction | RC3H2 interactions | 3.18e-04 | 667 | 29 | 6 | int:RC3H2 | |
| Interaction | SRP9 interactions | 3.26e-04 | 427 | 29 | 5 | int:SRP9 | |
| Interaction | PCBP1 interactions | 3.29e-04 | 671 | 29 | 6 | int:PCBP1 | |
| Interaction | PDZD8 interactions | 3.29e-04 | 428 | 29 | 5 | int:PDZD8 | |
| Interaction | PCDHGA10 interactions | 3.37e-04 | 19 | 29 | 2 | int:PCDHGA10 | |
| Interaction | G2E3 interactions | 3.37e-04 | 19 | 29 | 2 | int:G2E3 | |
| Interaction | RPF2 interactions | 3.46e-04 | 236 | 29 | 4 | int:RPF2 | |
| Interaction | PRC1 interactions | 3.67e-04 | 973 | 29 | 7 | int:PRC1 | |
| Interaction | NR3C1 interactions | 3.69e-04 | 974 | 29 | 7 | int:NR3C1 | |
| Interaction | CHMP4C interactions | 3.73e-04 | 687 | 29 | 6 | int:CHMP4C | |
| Interaction | USF3 interactions | 3.74e-04 | 20 | 29 | 2 | int:USF3 | |
| Interaction | NAA40 interactions | 3.78e-04 | 978 | 29 | 7 | int:NAA40 | |
| Interaction | SRP19 interactions | 3.92e-04 | 244 | 29 | 4 | int:SRP19 | |
| Interaction | EIF3L interactions | 3.92e-04 | 244 | 29 | 4 | int:EIF3L | |
| Interaction | TWF2 interactions | 3.94e-04 | 100 | 29 | 3 | int:TWF2 | |
| Interaction | H2BC14 interactions | 3.94e-04 | 100 | 29 | 3 | int:H2BC14 | |
| Interaction | H2AC6 interactions | 3.94e-04 | 100 | 29 | 3 | int:H2AC6 | |
| Interaction | PARP1 interactions | 4.03e-04 | 1316 | 29 | 8 | int:PARP1 | |
| Interaction | H3-4 interactions | 4.06e-04 | 448 | 29 | 5 | int:H3-4 | |
| Interaction | MYH15 interactions | 4.13e-04 | 21 | 29 | 2 | int:MYH15 | |
| Interaction | H2AC11 interactions | 4.17e-04 | 248 | 29 | 4 | int:H2AC11 | |
| Interaction | EIF3G interactions | 4.24e-04 | 249 | 29 | 4 | int:EIF3G | |
| Interaction | URB2 interactions | 4.30e-04 | 103 | 29 | 3 | int:URB2 | |
| Interaction | SMC5 interactions | 4.33e-04 | 1000 | 29 | 7 | int:SMC5 | |
| Interaction | MACROH2A1 interactions | 4.49e-04 | 458 | 29 | 5 | int:MACROH2A1 | |
| Interaction | SRPK2 interactions | 4.68e-04 | 717 | 29 | 6 | int:SRPK2 | |
| Interaction | H1-5 interactions | 4.72e-04 | 463 | 29 | 5 | int:H1-5 | |
| Interaction | CAPN6 interactions | 4.96e-04 | 23 | 29 | 2 | int:CAPN6 | |
| Interaction | CUL4B interactions | 5.07e-04 | 728 | 29 | 6 | int:CUL4B | |
| Interaction | EIF3E interactions | 5.21e-04 | 263 | 29 | 4 | int:EIF3E | |
| Interaction | PRRC2B interactions | 5.36e-04 | 265 | 29 | 4 | int:PRRC2B | |
| Interaction | PCDHGA6 interactions | 5.41e-04 | 24 | 29 | 2 | int:PCDHGA6 | |
| Interaction | PCDHGA7 interactions | 5.88e-04 | 25 | 29 | 2 | int:PCDHGA7 | |
| Interaction | REST interactions | 6.07e-04 | 274 | 29 | 4 | int:REST | |
| Interaction | SMNDC1 interactions | 6.09e-04 | 116 | 29 | 3 | int:SMNDC1 | |
| Interaction | ECI2 interactions | 6.09e-04 | 116 | 29 | 3 | int:ECI2 | |
| Interaction | TIMP2 interactions | 6.33e-04 | 277 | 29 | 4 | int:TIMP2 | |
| Interaction | DANCR interactions | 6.36e-04 | 26 | 29 | 2 | int:DANCR | |
| Interaction | H2AC12 interactions | 6.40e-04 | 118 | 29 | 3 | int:H2AC12 | |
| Interaction | MTHFD1 interactions | 6.50e-04 | 279 | 29 | 4 | int:MTHFD1 | |
| Interaction | ENTREP3 interactions | 6.72e-04 | 120 | 29 | 3 | int:ENTREP3 | |
| Interaction | AREL1 interactions | 6.86e-04 | 27 | 29 | 2 | int:AREL1 | |
| Interaction | ETS1 interactions | 6.88e-04 | 121 | 29 | 3 | int:ETS1 | |
| Interaction | EYA2 interactions | 6.88e-04 | 121 | 29 | 3 | int:EYA2 | |
| Interaction | IGF2BP1 interactions | 7.18e-04 | 508 | 29 | 5 | int:IGF2BP1 | |
| Interaction | DNM2 interactions | 7.32e-04 | 288 | 29 | 4 | int:DNM2 | |
| Interaction | DUSP6 interactions | 7.39e-04 | 124 | 29 | 3 | int:DUSP6 | |
| Interaction | RPS20 interactions | 7.51e-04 | 513 | 29 | 5 | int:RPS20 | |
| Interaction | TLX3 interactions | 7.61e-04 | 291 | 29 | 4 | int:TLX3 | |
| Interaction | XRCC5 interactions | 7.64e-04 | 515 | 29 | 5 | int:XRCC5 | |
| Interaction | RIOK2 interactions | 7.74e-04 | 126 | 29 | 3 | int:RIOK2 | |
| Interaction | PPIG interactions | 7.92e-04 | 127 | 29 | 3 | int:PPIG | |
| Interaction | NCL interactions | 8.23e-04 | 798 | 29 | 6 | int:NCL | |
| Interaction | BTF3 interactions | 8.28e-04 | 799 | 29 | 6 | int:BTF3 | |
| Interaction | SLC15A2 interactions | 8.48e-04 | 30 | 29 | 2 | int:SLC15A2 | |
| Interaction | DOT1L interactions | 8.72e-04 | 807 | 29 | 6 | int:DOT1L | |
| Interaction | CD81 interactions | 8.84e-04 | 303 | 29 | 4 | int:CD81 | |
| Cytoband | 5q31 | 8.45e-07 | 115 | 29 | 4 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 1.16e-06 | 298 | 29 | 5 | chr5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q21 | 3.60e-03 | 141 | 29 | 2 | chr12q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p31 | 8.82e-03 | 224 | 29 | 2 | chr1p31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 8.97e-03 | 226 | 29 | 2 | chr2q37 | |
| Cytoband | 6p21.3 | 1.09e-02 | 250 | 29 | 2 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | 2.37e-02 | 378 | 29 | 2 | chr6p22 | |
| GeneFamily | Clustered protocadherins | 6.63e-07 | 64 | 20 | 4 | 20 | |
| GeneFamily | Canonical high mobility group | 6.36e-05 | 11 | 20 | 2 | 511 | |
| GeneFamily | RNA binding motif containing | 2.28e-02 | 213 | 20 | 2 | 725 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 2.38e-05 | 318 | 29 | 5 | M41707 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN | 6.47e-05 | 198 | 29 | 4 | M4446 | |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN | 6.73e-05 | 200 | 29 | 4 | M3202 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP | 7.75e-05 | 12 | 29 | 2 | MM732 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP | 7.75e-05 | 12 | 29 | 2 | M1748 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 175 | 29 | 4 | 758a1796b823118ce52f989ef5e1076f8c8ac4c5 | |
| ToppCell | facs-Thymus-Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-06 | 185 | 29 | 4 | c0587b32f9925052016a06422ddcdc2ad9b7fc93 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-06 | 187 | 29 | 4 | 376a95ac1e38f61f8db5d23d9a905f8dae8c40b6 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.74e-06 | 190 | 29 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.88e-06 | 191 | 29 | 4 | fca19f2719806f3dc2dd2add7252ab1198548f4d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.88e-06 | 191 | 29 | 4 | 588015d76b68488da6aa6603777682f3d81592bf | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.88e-06 | 62 | 29 | 3 | 91c49ae176d2a418a58398e9d5e55c77187cc2fb | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.88e-06 | 62 | 29 | 3 | 3275775572a65460b6248ee72b4c85e4d4dee424 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.02e-04 | 140 | 29 | 3 | eb1d22f5f5dbf60b6485464baec4be9b3060f65c | |
| ToppCell | Cerebellum|World / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 147 | 29 | 3 | dd730224e39571ca2c35042e242a908a02ee377d | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 158 | 29 | 3 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 158 | 29 | 3 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-04 | 161 | 29 | 3 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-04 | 164 | 29 | 3 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.62e-04 | 164 | 29 | 3 | 47355439e578d1b1a387fb4ee761162028abea4a | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-04 | 165 | 29 | 3 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-04 | 165 | 29 | 3 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 166 | 29 | 3 | d1c61270c7b39bb365020eeafe298a8f88aa887e | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-04 | 166 | 29 | 3 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 169 | 29 | 3 | 0054f9bfd4d377c7fd94873c1308622051c59a8e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 169 | 29 | 3 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 169 | 29 | 3 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 171 | 29 | 3 | 0597339618fb4d416d55c538eceb353218a55002 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 171 | 29 | 3 | 0de81d12a8000f2c59cdb214e67dc526d18098fe | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.83e-04 | 171 | 29 | 3 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-04 | 178 | 29 | 3 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasmablasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.10e-04 | 179 | 29 | 3 | 58c8996120637315dcbd1991a71516c09173051e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 180 | 29 | 3 | 6111aefb7b00047a5a265838353dc163036ad95a | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 181 | 29 | 3 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 181 | 29 | 3 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 181 | 29 | 3 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 181 | 29 | 3 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-04 | 182 | 29 | 3 | 862cc68006918e9e46e22b236302d862737f1061 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 183 | 29 | 3 | 7534587fa35837c0aaca93c542f2eee493eba637 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.31e-04 | 185 | 29 | 3 | bb87fa174f80706fe7be60d3b9fc3e2a6b373038 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-04 | 187 | 29 | 3 | 31f36e34669b8fff6905262b4661b59c93e4dc3d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 188 | 29 | 3 | 483d7494704e8732a478b0ffee2f877ee824a6cf | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-MALT_B_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.46e-04 | 189 | 29 | 3 | 05e8fb483ebb9010cc54b39d78cca960c58c0f01 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.50e-04 | 190 | 29 | 3 | 5ec49cc7692053c1a525ca9137c996ccd2794e1c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-04 | 191 | 29 | 3 | b6cc0a9ced40ce5f80065d24d5bc20e3838a7682 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.54e-04 | 191 | 29 | 3 | 208cd307826b5af89f8f10c0c915f90f80a25c6c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.58e-04 | 192 | 29 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | E15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-04 | 192 | 29 | 3 | 4a0fb4ef8a9281489ffb0881421c9d691c52019c | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.62e-04 | 193 | 29 | 3 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 193 | 29 | 3 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 194 | 29 | 3 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 194 | 29 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.66e-04 | 194 | 29 | 3 | ded64ddab86de17fcf8b70d31bc26796eb71d60f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.70e-04 | 195 | 29 | 3 | 6eb123cbea7bcadbdef086a8c230f0a73caf4930 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-04 | 195 | 29 | 3 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.74e-04 | 196 | 29 | 3 | 0ff8cfb209063a8b217df6690ac1dec89004593f | |
| ToppCell | (2)_B_cells-(2)_Plasma_cells|(2)_B_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.74e-04 | 196 | 29 | 3 | cc4f59b885d58e43471e85c51d8e366e68d10846 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.74e-04 | 196 | 29 | 3 | 1f63dba9d226e4a42d9bee7258580a1e547c0e92 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.74e-04 | 196 | 29 | 3 | 74093f85e095606d1c723e0d7c2d78d9cfa47c4f | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.78e-04 | 197 | 29 | 3 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | ILEUM-inflamed-(5)_Plasmablasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.78e-04 | 197 | 29 | 3 | 8710a586fc91cf664032a12e4d2a0399b370cbcb | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.78e-04 | 197 | 29 | 3 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-04 | 198 | 29 | 3 | 1fa213e79d828bff6465bde116536dd1b80d94e0 | |
| ToppCell | B_cells-Plasmablasts|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.82e-04 | 198 | 29 | 3 | c6cab47885be74a64351f843a741dea6d911bde4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.82e-04 | 198 | 29 | 3 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 199 | 29 | 3 | bb201deb281619113edcd1de2af2d3eb21b967b8 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.86e-04 | 199 | 29 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 199 | 29 | 3 | 0649a2c5b8b1f01bb4c4d1eb114cf78a32f8ccd8 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 199 | 29 | 3 | e3e28981783b922027cee7fe8863386b02c7c758 | |
| ToppCell | HSPCs|World / Lineage and Cell class | 2.86e-04 | 199 | 29 | 3 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | Biopsy_Control_(H.)|World / Sample group, Lineage and Cell type | 2.86e-04 | 199 | 29 | 3 | 254c255292d9810fcea017526eae5ddb3a465ce3 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.90e-04 | 200 | 29 | 3 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.90e-04 | 200 | 29 | 3 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Radial_glial-RG|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-04 | 200 | 29 | 3 | b3775715b66aee18cff469bf3dbe9c305671c6d6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Radial_glial|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-04 | 200 | 29 | 3 | 9069e8d3bcc5f44baa00f2abb6cffd87586c3eab | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 200 | 29 | 3 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.90e-04 | 200 | 29 | 3 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.90e-04 | 200 | 29 | 3 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.90e-04 | 200 | 29 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.42e-03 | 86 | 29 | 2 | db67c05c876a5649371c0dc6c941cc371bc2feb8 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Tmsb4x_(Tmsb4x)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.42e-03 | 86 | 29 | 2 | 2778446e035c5585bce28ed0ef93b87b6ad90c6e | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-03 | 89 | 29 | 2 | d8832dbe69d3490ceaa05ccc99d7c81707803925 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-3|TCGA-Thymus / Sample_Type by Project: Shred V9 | 2.02e-03 | 103 | 29 | 2 | 91fe062dcadd12fdb04fa4593a794c57f3f0411d | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.06e-03 | 104 | 29 | 2 | 5114600bbadb5a0d31c164afd2e8c2a7865a1423 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.22e-03 | 108 | 29 | 2 | 63d45cc3ee149a7baf255b70409f8ea54c56157b | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.22e-03 | 108 | 29 | 2 | d57eeda825b6e0e64bae185896ae7eea6a2a50e9 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.22e-03 | 108 | 29 | 2 | db8472616886c6195f8c27c00f00133a9c10691d | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.22e-03 | 108 | 29 | 2 | c2aa6bf8554bfb6b0f9c5f6658601c6cf7c8bdbc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.30e-03 | 110 | 29 | 2 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | Control-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.73e-03 | 120 | 29 | 2 | 62d3a731d36802c9da8674a042a8604cdb86263a | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.78e-03 | 121 | 29 | 2 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | Control-B_naive-9|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.87e-03 | 123 | 29 | 2 | 36d509eae874733f1a4f8189ad3000136ff6425e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.91e-03 | 124 | 29 | 2 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.01e-03 | 126 | 29 | 2 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.01e-03 | 126 | 29 | 2 | a1ea8cf6b444a640544d204dfaf5ff219dc31aa9 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.01e-03 | 126 | 29 | 2 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.01e-03 | 126 | 29 | 2 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.01e-03 | 126 | 29 | 2 | 2de551d7a8765afec1da8852727c79fec90f45f8 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.01e-03 | 126 | 29 | 2 | 3d507f829882d043f633db2612b76936e2042445 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.05e-03 | 127 | 29 | 2 | aca98d8c91f2aa0a777b6e9480c9ea70d38ff393 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.29e-03 | 132 | 29 | 2 | 4e37400ae7375e6986f060234c373194603346f8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.39e-03 | 134 | 29 | 2 | b5466759285b4973850afb2e1be7c1d25f1c7927 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.44e-03 | 135 | 29 | 2 | 35928195cf34f055b353562c96f451aef2344d64 | |
| Disease | mental development measurement | 9.38e-09 | 25 | 29 | 4 | EFO_0008230 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 6.98e-07 | 71 | 29 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Sarcosine measurement | 1.49e-06 | 23 | 29 | 3 | EFO_0021668 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.44e-04 | 152 | 29 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | 6.20e-04 | 1106 | 29 | 6 | EFO_0021796 | |
| Disease | Familial dilated cardiomyopathy | 8.60e-04 | 44 | 29 | 2 | C0340427 | |
| Disease | FEV/FEC ratio | 1.07e-03 | 1228 | 29 | 6 | EFO_0004713 | |
| Disease | asthma exacerbation measurement, response to corticosteroid | 1.15e-03 | 51 | 29 | 2 | EFO_0007614, GO_0031960 | |
| Disease | squamous cell carcinoma | 1.98e-03 | 67 | 29 | 2 | EFO_0000707 | |
| Disease | synophrys measurement | 2.04e-03 | 68 | 29 | 2 | EFO_0007906 | |
| Disease | Antihypertensive use measurement | 2.20e-03 | 265 | 29 | 3 | EFO_0009927 | |
| Disease | Alzheimer disease, polygenic risk score | 2.47e-03 | 586 | 29 | 4 | EFO_0030082, MONDO_0004975 | |
| Disease | mean platelet volume | 2.91e-03 | 1020 | 29 | 5 | EFO_0004584 | |
| Disease | sunburn | 4.02e-03 | 96 | 29 | 2 | EFO_0003958 | |
| Disease | suntan | 4.61e-03 | 103 | 29 | 2 | EFO_0004279 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AASGEAKPKVKKAGG | 111 | P16403 | |
| EKKAGHNYGPGGNKK | 2556 | Q96DT5 | |
| AEPQAAGGGQKKGDK | 41 | P23582 | |
| GGDGDEKDKKKANLP | 341 | P20020 | |
| IAAEQKANPDGKKKG | 211 | Q9UKM9 | |
| DGKAPAGGNGNKKKS | 911 | Q9Y5G8 | |
| LKAAENKKKEAGGGG | 31 | Q8NC51 | |
| AGKKPASEKAKNGRD | 426 | O75140 | |
| KKGKADAGKEGNNPA | 56 | P05204 | |
| DGKAPAGGNGNKKKS | 916 | Q9Y5H3 | |
| DGKAPAGGNGNKKKS | 911 | Q9Y5G2 | |
| RKGKADAGKDGNNPA | 56 | O00479 | |
| GAAIPAKGAKNGKNA | 126 | P19338 | |
| SENAPGDGKGNKHKK | 921 | Q7Z6E9 | |
| KSNEGADGPVKNKKK | 161 | Q92838 | |
| RKKKEPGDQEGAAKG | 96 | Q8TD26 | |
| AADKGKKNAGNAEDP | 531 | O95817 | |
| DGKAPAGGNGNKKKS | 911 | Q9Y5H4 | |
| GCGGADDPAKKKKQR | 76 | P78337 | |
| DKGKGKSAEGQPKFG | 636 | Q9HAZ2 | |
| KPAKGKGKDQPEANA | 176 | Q6Q759 | |
| QGNKAEKAGSKEQGP | 101 | Q9HCU5 | |
| KAEGTPNQGKKAEGA | 251 | Q9P2E9 | |
| KAEGAQNQGKKGEGA | 311 | Q9P2E9 | |
| KGEGAQNQGKKAEGA | 321 | Q9P2E9 | |
| QGKKAEGSPSEGKKA | 566 | Q9P2E9 | |
| EGKKAEGSPNQGKKA | 576 | Q9P2E9 | |
| EGGKKVSKKSNGAPN | 51 | Q9BQI5 | |
| KAAGGQDKAGKEKGV | 176 | Q5JSZ5 | |
| LNKPNSGKNDDKGNK | 36 | Q8IWU9 | |
| AGKNSGKKKGLNNEL | 656 | Q9ULD9 | |
| EKFAPKKQGDGGKDL | 266 | Q96AX1 | |
| KKQGDGGKDLPTEAK | 271 | Q96AX1 | |
| GKKPVKENQSEGKGS | 81 | Q9UN37 |